, () () . . , ( 5) (Joern W.-P. Michael, 2010) (Zhang W, 2010) (Grotle M, 2007).
|
|
|
|
50 |
|
|
( , ) |
, .. |
|
|
|
|
|
|
|
|
|
|
(, , , ) |
|
(AnandacoomarasamyAC. I., 2008)(AnandacoomarasamyAF. M., 2009)(SzoekeC, 2006) (LeeR, KeanWF., 2012) (KingLK, MarchL, 2013), (AltmanR.D., 2000) (ArborA., 2002) (AAOS , 2013) (FernandesL, April 17, 2013) (ZhangWD. M., publishedonlinefirst 07.10.2004) (NationalCollaboratingCentreforChronicConditions, 2008), .
(JiangL, 2011) (JiangLT. W., 2012). (), .
([Noauthors], October 2000) (WHO (Geneva), June 1997):
| (), /2 = () / ()2. |
, . 18 24,9. 25 29,9. 30 .
JiangL. . (JiangLR. J., 2011), , 5 35%, – 11%. , . Blagojevic. . (Blagojevic M, 2010) 2,63 , , ToivanenA.T. . (ToivanenAT, 2010) 7 , 30 /2 , 25 /2. (Holliday KL, 2011) (King LK, March L, 2013)(Coggon D, 2001)
- , , . , .
, , . , (Runhaar J, 2011) (King LK, 2008). , , (Oliveria SA, 1999) (Ouchi N, 2011).
. , , , . ReijmanM (Reijman M, 2007). , : 10 , – 2,5 , .
, (Liu B, 2007). LohmanderL.S. . (Lohmander LS, 2009), 8,1 , – 2,6 . LiuB . (Liu B, 2007) , , , 69% 27% .
, , , , .. , 1,9-13 (Kellgren JH, Lawrence JS, 1958) (Kellgren JH, Moore R, 1952) (Greinemann H, 1988). , , . , , ..
: , ,
? !
:


























:
:
:




